Nyxoah (NYXH) Cash & Current Investments (2020 - 2025)
Nyxoah's (NYXH) quarterly Cash & Current Investments came in at $30.1 million in Q4 2025, down 67.06% year-on-year from $91.4 million in Q4 2024, and down 99.76% quarter-over-quarter from $12.7 billion in Q3 2025.
Nyxoah (NYXH) Cash & Current Investments (2020 - 2025) Analysis & Trends
Nyxoah's Cash & Current Investments history runs 6 years deep, the most recent figure standing at $30.1 million for Q4 2025.
- On a quarterly basis, Cash & Current Investments fell 67.06% year-over-year to $30.1 million in Q4 2025; TTM through Mar 2026 was -$47.0 million, a 170.85% decrease from a year earlier, with the FY2025 full-year figure at $30.1 million, down 67.06% from the prior year.
- Cash & Current Investments declined to $30.1 million in Q4 2025 per NYXH's latest filing, from $12.7 billion in the prior quarter.
- Across five years, Cash & Current Investments topped out at $25.7 billion in Q3 2022 and bottomed at -$47.0 million in Q2 2022.
- The 5-year median for Cash & Current Investments is $66.3 million (2025), against an average of $2.3 billion.
- Across the five-year window, Cash & Current Investments tumbled 152.17% in 2024 and soared 30897.53% in 2025, its largest moves.
- Year by year, Cash & Current Investments stood at $155.0 million in 2021, then tumbled by 88.23% to $18.3 million in 2022, then advanced by 29.42% to $23.6 million in 2023, then surged by 287.06% to $91.4 million in 2024, then slumped by 67.06% to $30.1 million in 2025.
- Per Business Quant, the three latest NYXH Cash & Current Investments figures stand at $30.1 million (Q4 2025), $12.7 billion (Q3 2025), and $48.7 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 5.22 Bn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | 816.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 1.66 Bn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | 2.24 Bn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 1.66 Bn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | 561.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | 138.80 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 1.06 Bn |
| 10 | Nyxoah | 53.92 Mn | 100.91 Mn | 4.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.11 Mn |
| Sep 30, 2025 | 12.68 Bn |
| Jun 30, 2025 | 48.66 Mn |
| Mar 31, 2025 | 66.32 Mn |
| Dec 31, 2024 | 91.42 Mn |
| Sep 30, 2024 | -41.17 Mn |
| Jun 30, 2024 | -33.86 Mn |
| Mar 31, 2024 | 48.13 Mn |
| Dec 31, 2023 | 23.62 Mn |
| Sep 30, 2023 | 78.91 Mn |
| Jun 30, 2023 | 92.04 Mn |
| Mar 31, 2023 | 103.11 Mn |
| Dec 31, 2022 | 18.25 Mn |
| Sep 30, 2022 | 25.72 Bn |
| Jun 30, 2022 | -46.98 Mn |
| Mar 31, 2022 | 143.47 Mn |
| Dec 31, 2021 | 155.02 Mn |
| Dec 31, 2020 | 110.05 Mn |